124 related articles for article (PubMed ID: 36369191)
1. Quantitative Radiological Features and Deep Learning for the Non-Invasive Evaluation of Programmed Death Ligand 1 Expression Levels in Gastric Cancer Patients: A Digital Biopsy Study.
Xie W; Jiang Z; Zhou X; Zhang X; Zhang M; Liu R; Zheng L; Xin F; Lu Y; Wang D
Acad Radiol; 2023 Jul; 30(7):1317-1328. PubMed ID: 36369191
[TBL] [Abstract][Full Text] [Related]
2. Can PD-L1 expression be predicted by contrast-enhanced CT in patients with gastric adenocarcinoma? a preliminary retrospective study.
Gu X; Yu X; Shi G; Li Y; Yang L
Abdom Radiol (NY); 2023 Jan; 48(1):220-228. PubMed ID: 36271155
[TBL] [Abstract][Full Text] [Related]
3. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
4. Non-Invasive Measurement Using Deep Learning Algorithm Based on Multi-Source Features Fusion to Predict PD-L1 Expression and Survival in NSCLC.
Wang C; Ma J; Shao J; Zhang S; Li J; Yan J; Zhao Z; Bai C; Yu Y; Li W
Front Immunol; 2022; 13():828560. PubMed ID: 35464416
[TBL] [Abstract][Full Text] [Related]
5. A computed tomography-based radiomics signature for predicting expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
Zheng YM; Yuan MG; Zhou RQ; Hou F; Zhan JF; Liu ND; Hao DP; Dong C
Eur Radiol; 2022 Aug; 32(8):5362-5370. PubMed ID: 35298679
[TBL] [Abstract][Full Text] [Related]
6. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
7. A CT-based radiomics signature for preoperative discrimination between high and low expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
Zheng YM; Zhan JF; Yuan MG; Hou F; Jiang G; Wu ZJ; Dong C
Eur J Radiol; 2022 Jan; 146():110093. PubMed ID: 34890937
[TBL] [Abstract][Full Text] [Related]
8. Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer.
Meißner AK; Gutsche R; Galldiks N; Kocher M; Jünger ST; Eich ML; Nogova L; Araceli T; Schmidt NO; Ruge MI; Goldbrunner R; Proescholdt M; Grau S; Lohmann P
J Neurooncol; 2023 Jul; 163(3):597-605. PubMed ID: 37382806
[TBL] [Abstract][Full Text] [Related]
9. Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images.
Tian P; He B; Mu W; Liu K; Liu L; Zeng H; Liu Y; Jiang L; Zhou P; Huang Z; Dong D; Li W
Theranostics; 2021; 11(5):2098-2107. PubMed ID: 33500713
[No Abstract] [Full Text] [Related]
10. Deep learning radiomics model based on PET/CT predicts PD-L1 expression in non-small cell lung cancer.
Li B; Su J; Liu K; Hu C
Eur J Radiol Open; 2024 Jun; 12():100549. PubMed ID: 38304572
[TBL] [Abstract][Full Text] [Related]
11. A deep-learning model using enhanced chest CT images to predict PD-L1 expression in non-small-cell lung cancer patients.
Liu PM; Feng B; Shi JF; Feng HJ; Hu ZJ; Chen YH; Zhang JP
Clin Radiol; 2023 Oct; 78(10):e689-e697. PubMed ID: 37460338
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images.
Mu W; Jiang L; Shi Y; Tunali I; Gray JE; Katsoulakis E; Tian J; Gillies RJ; Schabath MB
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34135101
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Tumor PD-L1 Expression in Resectable Non-Small Cell Lung Cancer by Machine Learning Models Based on Clinical and Radiological Features: Performance Comparison With Preoperative Biopsy.
Hashimoto K; Murakami Y; Omura K; Takahashi H; Suzuki R; Yoshioka Y; Oguchi M; Ichinose J; Matsuura Y; Nakao M; Okumura S; Ninomiya H; Nishio M; Mun M
Clin Lung Cancer; 2024 Jan; 25(1):e26-e34.e6. PubMed ID: 37673781
[TBL] [Abstract][Full Text] [Related]
14. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
Jiang Y; Liang X; Han Z; Wang W; Xi S; Li T; Chen C; Yuan Q; Li N; Yu J; Xie Y; Xu Y; Zhou Z; Poultsides GA; Li G; Li R
Lancet Digit Health; 2021 Jun; 3(6):e371-e382. PubMed ID: 34045003
[TBL] [Abstract][Full Text] [Related]
15. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [
Zhao X; Zhao Y; Zhang J; Zhang Z; Liu L; Zhao X
EJNMMI Res; 2023 Jan; 13(1):4. PubMed ID: 36682020
[TBL] [Abstract][Full Text] [Related]
16. A virtual biopsy study of microsatellite instability in gastric cancer based on deep learning radiomics.
Jiang Z; Xie W; Zhou X; Pan W; Jiang S; Zhang X; Zhang M; Zhang Z; Lu Y; Wang D
Insights Imaging; 2023 Jun; 14(1):104. PubMed ID: 37286810
[TBL] [Abstract][Full Text] [Related]
17. CT-Based Hand-crafted Radiomic Signatures Can Predict PD-L1 Expression Levels in Non-small Cell Lung Cancer: a Two-Center Study.
Jiang Z; Dong Y; Yang L; Lv Y; Dong S; Yuan S; Li D; Liu L
J Digit Imaging; 2021 Oct; 34(5):1073-1085. PubMed ID: 34327623
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
Wang W; Peng Y; Feng X; Zhao Y; Seeruttun SR; Zhang J; Cheng Z; Li Y; Liu Z; Zhou Z
JAMA Netw Open; 2021 Aug; 4(8):e2121143. PubMed ID: 34410397
[TBL] [Abstract][Full Text] [Related]
19. Radiomics-based prediction model for outcomes of PD-1/PD-L1 immunotherapy in metastatic urothelial carcinoma.
Park KJ; Lee JL; Yoon SK; Heo C; Park BW; Kim JK
Eur Radiol; 2020 Oct; 30(10):5392-5403. PubMed ID: 32394281
[TBL] [Abstract][Full Text] [Related]
20. Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma.
Gong XQ; Liu N; Tao YY; Li L; Li ZM; Yang L; Zhang XM
Sci Rep; 2023 May; 13(1):7710. PubMed ID: 37173350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
